Author

Nobuhiro Tagashira

Maebashi Institute of Technology - Cited by 5,033 - genome - epigenome - molecular biology - analytical chemistry

Biography

Satoshi Yamashita has done his Doctor of Agriculture. Currently, he is working as Professor in Department of Clinical Psychology at Tokushima University. His research interests are Forest Biology, Cluster Ecology, Hotanlin Ecology. Several Papers of his work were published in reputed international journals. she is also the member of Several governing bodies of his specialized area.
Title
Cited by
Year
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
K Fukuoka, Y Kanemura, T Shofuda, S Fukushima, S Yamashita, ...Acta neuropathologica communications 6 (1), 1-18, 2018201
79
2018
Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer’s disease
T Mano, K Nagata, T Nonaka, A Tarutani, T Imamura, T Hashimoto, ...Proceedings of the National Academy of Sciences 114 (45), E9645-E9654, 2017201
78
2017
Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues
S Yamashita, T Kishino, T Takahashi, T Shimazu, H Charvat, Y Kakugawa, ...Proceedings of the national academy of sciences 115 (6), 1328-1333, 2018201
75
2018
WNT pathway gene mutations are associated with the presence of dysplasia in colorectal sessile serrated adenoma/polyps
T Hashimoto, S Yamashita, H Yoshida, H Taniguchi, T Ushijima, ...The American journal of surgical pathology 41 (9), 1188-1197, 2017201
59
2017
Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3
M Maeda, H Takeshima, N Iida, N Hattori, S Yamashita, H Moro, ...Gut 69 (2), 243-251, 2020202
47
2020
TET repression and increased DNMT activity synergistically induce aberrant DNA methylation
H Takeshima, T Niwa, S Yamashita, T Takamura-Enya, N Iida, ...The Journal of clinical investigation 130 (10), 5370-5379, 2020202
41
2020
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication
M Maeda, S Yamashita, T Shimazu, N Iida, H Takeshima, T Nakajima, ...Gastric Cancer 21, 745-755, 2018201
38
2018
RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
K Pang, J Park, SG Ahn, J Lee, Y Park, A Ooshima, S Mizuno, ...Nature communications 10 (1), 5805, 2019201
31
2019
Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway
Y Nakamura, N Hattori, N Iida, S Yamashita, A Mori, K Kimura, T Yoshino, ...Cancer letters 402, 100-109, 2017201
31
2017
Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100
T Watanabe, S Yamashita, H Ureshino, K Kamachi, Y Kurahashi, ...Blood, The Journal of the American Society of Hematology 136 (7), 871-884, 2020202
27
2020
PRC2-mediated transcriptomic alterations at the embryonic stage govern tumorigenesis and clinical outcome in MYCN-driven neuroblastoma
S Tsubota, S Kishida, T Shimamura, M Ohira, S Yamashita, D Cao, ...Cancer research 77 (19), 5259-51, 2017201
27
2017
MACON: a web tool for computing DNA methylation data obtained by the Illumina Infinium Human DNA methylation BeadArray
N Iida, Y Okuda, O Ogasawara, S Yamashita, H Takeshima, T UshijimaEpigenomics 10 (3), 249-258, 2018201
22
2018
Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation
Y Nakano, D Hasegawa, DR Stewart, KAP Schultz, AK Harris, J Hirato, ...Modern Pathology 32 (12), 1744-1750, 2019201
22
2019
Distinct DNA methylation targets by aging and chronic inflammation: a pilot study using gastric mucosa infected with Helicobacter pylori
S Yamashita, S Nanjo, E Rehnberg, N Iida, H Takeshima, T Ando, ...Clinical Epigenetics 11 (1), 1-14, 191
20
2019
Clinicopathological and molecular correlations in traditional serrated adenoma
S Sekine, S Yamashita, M Yamada, T Hashimoto, R Ogawa, H Yoshida, ...Journal of Gastroenterology 55, 418-427, 2020202
16
2020
DNA methylation marker to estimate the breast cancer cell fraction in DNA samples
H Ishihara, S Yamashita, S Fujii, K Tanabe, H Mukai, T UshijimaMedical oncology 35, 1-9, 2018201
14
2018
Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas
N Asano, H Takeshima, S Yamashita, H Takamatsu, N Hattori, T Kubo, ...Scientific reports 9 (1), 20360, 2019201
14
2019
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy
S Yamashita, N Hattori, S Fujii, T Yamaguchi, M Takahashi, Y Hozumi, ...Scientific Reports 10 (1), 15530, 2020202
13
2020
FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy
J Iwabu, S Yamashita, H Takeshima, T Kishino, T Takahashi, I Oda, ...Scientific reports 9 (1), 13347, 2019201
12
2019
Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end‐stage renal disease
H Ishihara, S Yamashita, YY Liu, N Hattori, O El‐Omar, T Ikeda, H Fukuda, ...Cancer Science 111 (11), 4276-4287, 2020202
10
2020

Referred From: https://scholar.google.com/citations?user=LHQFan8AAAAJ&hl=en

Cited by
Citations 5033
h-index 41
i10-index 89
Recommended Journals
Open Access Journals